NIPA1 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal population of Raji B lymphocytes with targeted disruption of the NIPA1 gene. This loss-of-function model enables investigation of magnesium transporter activity and bone morphogenetic protein (BMP) signaling regulation in a human lymphoid background. The polyclonal format provides a heterogeneous pool of edited cells suitable for population-level functional genomics and drug screening.
The Raji cell line, derived from Burkitt??s lymphoma, harbors Epstein-Barr virus (EBV) and exhibits a type III latency pattern. Raji cells grow as suspension lymphoblasts and are widely used to study B cell malignancies, EBV-dependent transformation, and apoptotic signaling. Their rapid proliferation and well-characterized transcriptome facilitate CRISPR/Cas9-mediated gene knockout and subsequent functional assays.
NIPA1 encodes a magnesium transporter that negatively regulates BMP signaling by binding to BMP type II receptors (BMPR2) and promoting their endocytic degradation via the adaptor ZFYVE9/SARA. This reduces BMP2- and BMP4-dependent phosphorylation of SMAD1, SMAD5, and SMAD8, limiting their complex formation with SMAD4 and subsequent transcriptional activation of ID family target genes. NIPA1 activity is modulated by cellular magnesium concentrations and interacts with hereditary spastic paraplegia proteins ATL1 and SPAST. Disruption of NIPA1 in Raji cells relieves pathway inhibition, leading to enhanced SMAD signaling and altered transcriptional programs.
In Raji B lymphocytes, BMP signaling regulates proliferation, differentiation, and apoptosis. Loss of NIPA1 likely elevates SMAD phosphorylation and ID gene expression, potentially influencing cell fate determination and EBV latency maintenance. This model is valuable for dissecting crosstalk between magnesium homeostasis, BMP pathway activity, and B cell lymphoma biology, and provides a non-neuronal system to investigate hereditary spastic paraplegia-related mechanisms.
Researchers may utilize NIPA1 Knockout Raji Polyclonal Cells in western blotting to assess SMAD1/5/8 phosphorylation, RT-qPCR for ID gene expression, luciferase reporter assays to measure SMAD-responsive transcription, co-immunoprecipitation to examine NIPA1?CBMPR2 complexes, and flow cytometry for apoptosis or proliferation endpoints. Key applications include mechanistic studies of BMP signaling in B lymphocytes, functional analysis of magnesium transporter activity, drug screening for BMP pathway modulators, and lymphoma-focused functional genomics. For further technical details, please contact Ascent Research.
